Zimbabwe has declined a significant American health deal worth 367 million US dollars (£272m) over five years due to Washington's request for confidential data.
This move was revealed after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "skewed".
A government spokesman has since explained that the United States was requesting health data for scientific study and profit while was unwilling to guarantee the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for further talks to find a deal suitable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Context
This rejection follows a similar case in Kenya, where a high court suspended a related health funding agreement after legal challenges were raised about the safety of citizens' health data.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.
As per statements, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population if a future pandemic arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously established via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This framework is designed to guarantee that when a country provides its information, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our US partners on how future collaboration could be arranged in a manner that respects the independence and dignity of both nations."
Health Experts Reaction
A leading public health body expressed it understood the official position, but urged that negotiations must proceed considering much of the country's Aids initiatives relied on international support.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," the group added.
This impasse underscores the ongoing tensions between accepting vital foreign assistance and safeguarding a country's data in an ever more interconnected world.